Literature DB >> 990979

The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

B A Britt, L Endrenyi, W Kalow, P L Peters.   

Abstract

The adenosine triphosphate (ATP depletion ratio, which is the ratio [ATP] in skeletal muscle equilibrated with carbogen and 4% halothane for 30 minutes divided by [ATP] in skeletal muscle equilibrated with carbogen alone for 30 minutes is less than normal in most but not in all rigid MHS patients. The ratio is normal in non-rigid MHS patients. This diagnostic tool is, therefore, useful in the diagnosis of rigid MH. It is not, however, such a sensitive diagnostic parameter as the caffeine contracture test.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990979     DOI: 10.1007/bf03006745

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  36 in total

1.  Malignant hyperthermia in a family. The ultrastructure of muscle biopsies of healthy members.

Authors:  E Reske-Nielsen; J Haase; J Kelstrup
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-11

2.  Inheritance of malignant hyperpyrexia.

Authors:  J O King; M A Denborough; P W Zapf
Journal:  Lancet       Date:  1972-02-12       Impact factor: 79.321

3.  Recent advances in malignant hyperthermia.

Authors:  B A Britt
Journal:  Anesth Analg       Date:  1972 Sep-Oct       Impact factor: 5.108

4.  Biochemical changes in malignant hyperpyrexia.

Authors:  M A Denborough; J F Forster; M C Hudson; N G Carter; P Zapf
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

5.  Myopathy and malignant hyperpyrexia.

Authors:  M A Denborough; P Ebeling; J O King; P Zapf
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

6.  Malignant hyperthermia--an investigation of three patients.

Authors:  B A Britt
Journal:  Ann R Coll Surg Engl       Date:  1971-02       Impact factor: 1.891

Review 7.  Malignant hyperthermia: a statistical review.

Authors:  B A Britt; W Kalow
Journal:  Can Anaesth Soc J       Date:  1970-07

8.  Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

Authors:  W Kalow; B A Britt; M E Terreau; C Haist
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

9.  Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome.

Authors:  H Isaacs; J J Heffron
Journal:  Br J Anaesth       Date:  1975-04       Impact factor: 9.166

10.  Malignant hyperthermia in a family. The neurophysiological and light microscopical study of muscle biopsies of healthy members.

Authors:  E Reske-Nielsen; J Haase; J Kelstrup
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-11
View more
  9 in total

1.  Evaluation of a commercial creatine kinase screening test for malignant hyperthermia (porcine stress syndrome).

Authors:  W N McDonell; D C Seeler; P K Basrur
Journal:  Can J Vet Res       Date:  1986-10       Impact factor: 1.310

2.  The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results.

Authors:  A K Brownell; M Szabo
Journal:  Can Anaesth Soc J       Date:  1982-05

3.  Malignant hyperthermia.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-11

4.  Comparison of effects of several inhalation anaesthetics on caffeine-induced contractures of normal and malignant hyperthermic skeletal muscle.

Authors:  B A Britt; L Endrenyi; W Frodis; E Scott; W Kalow
Journal:  Can Anaesth Soc J       Date:  1980-01

Review 5.  Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis.

Authors:  P J O'Brien; A Klip; B A Britt; B I Kalow
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

6.  Perfusion of malignant hyperthermia susceptible and normal isolated pig livers with halothane.

Authors:  B A Britt; B Shandling; L Endrenyl; G M Kent
Journal:  Can Anaesth Soc J       Date:  1978-09

7.  Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.

Authors:  T E Nelson
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

8.  Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).

Authors:  E H Flewellen; T E Nelson; D E Bee
Journal:  Can Anaesth Soc J       Date:  1980-01

9.  Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.

Authors:  B A Britt; W Frodis; E Scott; M J Clements; L Endrenyi
Journal:  Can Anaesth Soc J       Date:  1982-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.